Fig. 1
From: A real-world Pharmacovigilance study of brodalumab based on the FDA adverse event reporting system
Flowchart depicting the adverse event analysis process for brodalumab using the FDA Adverse Event Reporting System database. Abbreviations: DEMO, demographics; DRUG, drug information; REAC, adverse events; PS, primary suspect.
